BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Approvals (World)
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Wins FDA Approval For Arzerra As First-Line Treatment For Chronic Lymphocytic Leukaemia (CLL) 4/18/2014  More...
FDA Approves GlaxoSmithKline (GSK)'s Tanzeum To Treat Type 2 Diabetes 4/15/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) First Approval And Launch Of Generic Lovaza® Capsules In The United States 4/8/2014  More...
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In The European Union For A 2-Dose Schedule In Children Aged From 9 To 13 Years 4/7/2014  More...
Stallergenes, S.A. (GENP.PA) Wins FDA's Go-Ahead For Oralair Allergy Pill 4/2/2014  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets Approval For Influenza Vaccines 3/31/2014  More...
Swedish Orphan Biovitrum: FDA Approves Alprolix™ 3/31/2014  More...
GlaxoSmithKline (GSK)'s Type 2 Diabetes Drug Eperzan® Wins EU Approval 3/27/2014  More...
Actavis (ACT) And Valeant Pharmaceuticals International (VRX) Announce FDA Approval For Metronidazole 1.3% 3/26/2014  More...
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014  More...
Otsuka Pharmaceutical Co., Ltd.'s Samsca® Approved In Japan As The World's First Drug Therapy For ADPKD, A Rare Kidney Disease 3/24/2014  More...
Medivir AB (MVRBF): Simeprevir Has Now Been Approved In Russia 3/24/2014  More...
Pierre Fabre Obtains FDA Approval To Market Hemangeo™ For The Treatment Of Infantile Hemangioma 3/18/2014  More...
Starpharma Holdings Ltd Release: Vivagel®-Coated Condom Approved For Marketing In Japan 3/14/2014  More...
TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic 3/13/2014  More...
Northwest Biotherapeutics (NWBO) Jumps As Germany Permits Sale Of Brain Cancer Drug 3/11/2014  More...
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) Now Approved In Over 100 Countries For Stroke Prevention In Atrial Fibrillation 3/6/2014  More...
Vectura Group plc (VEC.L): South Korean Regulatory Authority Confirm Approval Of AirFluSal® Forspiro® 2/28/2014  More...
Oasmia Wins FDA Conditional Approval For Paccal Vet In Two Canine Cancers 2/28/2014  More...
BioDiem Ltd. (BDM.AX)'s Announcement Of Approval Of LAIV Seasonal Flu Vaccine In India 2/18/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces Full FDA Approval Of SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 2/13/2014  More...
The Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) Alliance Announces Once-Monthly (Pr)ABILIFY MAINTENA(™) (ARIPIPRAZOLE For Prolonged Release Injectable Suspension)1 Now Approved In Canada For The Maintenance Treatment Of Schizophrenia In Stabilized Adult Patients 2/13/2014  More...
Vectura Group plc (VEC.L) Release: Norwegian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 2/10/2014  More...
Genzyme Corporation (GENZ)’s Lemtrada® Approved In Mexico For Treatment Of Multiple Sclerosis 2/4/2014  More...
Perrigo Company (PRGO) Receives FDA Final Approval For Generic Equivalent To Prandin® 1/24/2014  More...
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs® CD34 Reagent System For Prevention Of Graft-Versus-Host Disease In The Treatment Of Acute Myeloid Leukemia 1/24/2014  More...
AstraZeneca PLC (AZN)'s Diabetes Drug Xigduo Approved In Europe 1/23/2014  More...
Apricus Biosciences (APRI)Announces National Phase Approval For Erectile Dysfunction Cream - Vitaros® In Belgium 1/23/2014  More...
Aegerion Pharmaceuticals, Inc. (AEGR)'s JUXTAPID® Capsules Approved In Mexico 1/20/2014  More...
Keryx Biopharmaceuticals (KERX) Announces Marketing Approval Of Ferric Citrate In Japan 1/17/2014  More...
Vectura Group plc (VEC.L) Hungarian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/16/2014  More...
Vectura Group plc (VEC.L) German Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/13/2014  More...
GlaxoSmithKline (GSK) Gains Accelerated FDA Approval For Combination Use Of Mekinist® (Trametinib) And Tafinlar® (Dabrafenib) 1/9/2014  More...
Celgene International Sárl (CELG) Release: ABRAXANE® Plus Gemcitabine Receives European Marketing Authorization For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 1/7/2014  More...
Lundbeck Inc. (LUN.CO) Wins EU Marketing Approval For Brintellix To Treat Adult Depression 1/3/2014  More...
Actelion Ltd. (ALIOF.PK)'s New Blood Pressure Drug Get EU Nod 12/23/2013  More...
Biota Pharmaceuticals, Inc. Reports That Laninamivir Octanoate Is Approved For The Prevention Of Influenza In Japan 12/23/2013  More...
Kanghong Pharma Gains CFDA Approval For China's First Innovative MAb 12/23/2013  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s Second Lung Drug ANORO™ ELLIPTA™ Wins FDA Approval 12/20/2013  More...
Vectura Group plc (VEC.L): Danish Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 12/18/2013  More...
AstraZeneca PLC (AZN)'s Fluenz Tetra Gets European Marketing Grant 12/6/2013  More...
European Medicines Agency Approves Once Every Two Weeks Dosing Option For CSL Behring UK Ltd's Hizentra® (Human Normal Immunoglobulin, SCIg) 12/5/2013  More...
Fresenius Medical Care's Velphoro® (PA21) Receives FDA Approval 12/2/2013  More...
GW Pharmaceuticals Announces Sativex® Regulatory Approval In Switzerland 11/27/2013  More...
Mylan Inc. (MYL)-BioCon Limited (BIOCON.NS) Receive First Indian Biosimilar Regulatory Approval For Herceptin® 11/26/2013  More...
BTG plc (BTG.L) Surges As Varicose Vein Treatment Grabs FDA Approval; Stock Up +13.75% At Market Close (November 26, 2013) 11/26/2013  More...
Janssen-Cilag International NV (JNJ)'s INVOKANA™ Wins Approval In The EU For Type 2 Diabetes Patients 11/26/2013  More...
GlaxoSmithKline (GSK)'s Pioneering Bird Flu Vaccine Gets FFA Sciences Approval 11/25/2013  More...
Bavarian Nordic (BAVA.CO) Receives Health Canada Approval Of IMVAMUNE Smallpox Vaccine 11/22/2013  More...
EU Approves Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO)'s Once-Monthly Abilify Maintena® For Schizophrenia 11/21/2013  More...
Swedish Orphan Biovitrum Receives Approval For Kineret® For Treatment Of Rare Disease CAPS 11/20/2013  More...
EU Approval For Bayer AG (BAYN.DE)'s Prostate Cancer Drug 11/19/2013  More...
GlaxoSmithKline (GSK)'s Asthma Drug Relvar Approved In Europe 11/18/2013  More...
Bayer HealthCare (BAY) Receives Approval For Xofigo® (radium Ra 223 dichloride) Injection In Europe 11/15/2013  More...
Hong Kong Authority Approves Mundipharma AG's Flutiform® (fluticasone propionate/formoterol fumarate), a New Treatment for Asthma 11/8/2013  More...
Lupin Ltd. (LUPN.BO) Receives FDA Approval for its New Drug Application for Antara® Capsules 10/23/2013  More...
Basilea Pharmaceutica (BSLN.SW): Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia 10/23/2013  More...
Boehringer Ingelheim Corporation's New Once-Daily Striverdi* (Olodaterol) Respimat® Gains Approval in First EU Countries 10/18/2013  More...
Novo Nordisk Canada Inc. (NVO) Release: Health Canada Approves Levemir® Flextouch® Prefilled Insulin Pen for the Treatment of Type 1 and Type 2 Diabetes 10/18/2013  More...
UCB Group (UCBJF.PK)'s Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults With Active Ankylosing Spondylitis 10/18/2013  More...
Novo Nordisk A/S (NVO)'s Novoeight Wins FDA Approval for Hemophilia A 10/16/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval of Generic TOBI® in the United States 10/14/2013  More...
FDA Approves Sanofi (France) (SAN.PA)'s Nasacort® Allergy 24HR for Over-the-Counter Use 10/11/2013  More...
Lundbeck Inc. (LUN.CO), Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Win FDA Approval for Depression Drug 10/1/2013  More...
UCB, Inc. (UCBJF.PK)'s Cimzia® Wins FDA Approval for Psoriatic Arthritis 9/30/2013  More...
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in South Africa 9/30/2013  More...
CSL Behring Gains Approval to License Hizentra® in Japan for the Treatment of Primary Immunodeficiency and Secondary Immunodeficiency 9/27/2013  More...
Medivir AB (MVIRb.F)'s Simeprevir Has Been Approved in Japan for the Treatment of Genotype 1 Chronic Hepatitis C Infection 9/27/2013  More...
European Commission (EC) Approves Gilead Sciences, Inc. (GILD)' Tybost™, a New Boosting Agent for HIV Therapy 9/26/2013  More...
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey 9/25/2013  More...
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey 9/25/2013  More...
Abstral® , Manufactured and Packaged by Recipharm AB for Kyowa Hakko Kirin, Has Been Approved in Japan 9/23/2013  More...
Sosei Group Corporation's First in Class Once-Daily Dual Bronchodilator Ultibro® Breezhaler® (QVA149) Approved for the Treatment of COPD in Europe 9/23/2013  More...
Orexo AB Announces the Approval of Abstral® in Japan 9/20/2013  More...
Vectura Group plc (VEC.L) Release: Approval of Once-Daily Dual Bronchodilator Ultibro® Inhalation Capsules in Japan (QVA149) for the Treatment of COPD 9/20/2013  More...
Sosei Group Corporation: First in Class Once-Daily Dual Bronchodilator Ultibro Inhalation Capsules (QVA149) Approved for the Treatment of COPD in Japan 9/20/2013  More...
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s RELVAR™ ELLIPTA™Gains Approval in Japan for the Treatment of Asthma 9/20/2013  More...
Skyepharma PLC (SKYEF) Release: Flutiform® Approved in Japan 9/20/2013  More...
Four-Strain AstraZeneca PLC (AZN) Flu Vaccine Wins EU Green Light 9/20/2013  More...
Huahai Pharma China-Approved to Produce AIDS Treatment 9/18/2013  More...
European Commission (EC) Approves Genzyme Corporation (GENZ)'s Multiple Sclerosis Treatment Lemtrada™ (alemtuzumab) 9/17/2013  More...
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Approval of Azacitidine for Injection 9/17/2013  More...
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s Generic Version of Roche (RHHBY)'s Xeloda 9/17/2013  More...
Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) Receives Marketing Approval in Japan for All Patients With aHUS 9/13/2013  More...
Medigus (MDGS.TA) Announces Marketing Approval From the Israeli Ministry of Health (MEA) for SRS™ System for the Treatment of Gastroesophageal Reflux Disease (GERD) 9/12/2013  More...
Bayer AG (BAYN.DE)'s Stivarga® (regorafenib) Tablets Approved in Europe 8/30/2013  More...
European Commission (EC) Approves Genzyme Corporation (GENZ)’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) 8/30/2013  More...
Zhejiang Beta's Conmana, a Cancer Drug, is a Big Winner 8/26/2013  More...
Bayer AG (BAYN.DE)'s Stivarga Approved for Further Indication in Japan 8/21/2013  More...
Alcon Canada Receives Approval for JETREA™ (Ocriplasmin) Solution for Intravitreal Injection, the First and Only Eye Medicine to Treat Sight-Threatening, Symptomatic Vitreomacular Adhesion 8/16/2013  More...
Additional GlaxoSmithKline (GSK) Quadrivalent Intramuscular Influenza Vaccine Approved by FDA 8/16/2013  More...
FDA Approves GlaxoSmithKline (GSK)'s HIV Drug 8/14/2013  More...
Cosmederm Gains CFDA Approval for Topical Skin Treatment 8/12/2013  More...
Celgene International Sárl (CELG)'s Oral Anti-Cancer Therapy Pomalidomide Gets European Commission (EC) Approval 8/9/2013  More...
European Commission (EC) Approves Janssen-Cilag International NV (JNJ)'s VELCADE® as a Frontline Induction Therapy Before Stem Cell Transplantation 8/8/2013  More...
Zoetis (ZTS) Joint Venture in China Receives Approval for Rui Lan An™ Swine Vaccine Against PRRS 8/5/2013  More...
FDA Expands Age Indication for Novartis AG (NVS)'s Menveo®, First and Only Quadrivalent Meningococcal Vaccine for Infants as Young as 2 Months of Age[1] 8/2/2013  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s DPP-4 Treatment for Type 2 Diabetes Approved in China 8/1/2013  More...
RaySearch Laboratories Receives Chinese Regulatory Approval for RayStation® 7/26/2013  More...
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive 7/25/2013  More...
GlaxoSmithKline (GSK) Release: Tafinlar™ and Mekinist™ Approved in Canada for Metastatic Melanoma 7/24/2013  More...
Novaliq GmbH Announces European Market Approval for NovaTears™ OTC 7/23/2013  More...
Pfizer Inc. (PFE)'s Arthritis Drug Xeljanz Approved in Switzerland, Argentina, Kuwait, United Arab Emirates 7/15/2013  More...
Roche (RHHBY) Wins Conditional EU Approval for Cancer Drug Erivedge 7/15/2013  More...
TGA of Australia Approves Vertex Pharmaceuticals (MA) (VRTX)'s KALYDECO for Cystic Fbrosis 7/10/2013  More...
FDA Approves Orexo AB's New Drug to Fight Opioid Addiction 7/9/2013  More...
Cell Therapeutics, Inc. (CTIC) Release: Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI™ (pixantrone) 7/8/2013  More...
FDA OKs Hisamitsu Pharmaceutical's First Nonhormonal Drug for Hot Flashes 7/2/2013  More...
Sanofi (France) (SAN.PA)'s Diabetes Treatment Lyxumia Approved in Japan 6/28/2013  More...
FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Drug as First OTC Morning After Pill, Lifts Age Limit 6/21/2013  More...
Roche (RHHBY)'s Avastin Approved in Japan for Treatment of Aggressive Brain Cancer 6/18/2013  More...
Apricus Biosciences (APRI) Receives European Approval for Vitaros® for the Treatment of Erectile Dysfunction 6/10/2013  More...
FDA Approves Sanofi Pasteur (SASY.PA) Influenza Vaccine 6/10/2013  More...
FDA OKs Flamel Technologies (FLML)' Bloxiverz 6/3/2013  More...
FDA Approves Two GlaxoSmithKline (GSK) Melanoma Drugs 5/31/2013  More...
European Commission (EC) Approves Gilead Sciences, Inc. (GILD)'s Stribild as Single Tablet Regimen for HIV-1 Treatment 5/28/2013  More...
GlaxoSmithKline (GSK)'s BREO™ ELLIPTA™ Receives Regulatory Approval in U.S. 5/13/2013  More...
FDA OKs Novartis AG (NVS) Drug for a Form of Childhood Arthritis 5/13/2013  More...
FDA Approves GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Drug for COPD Lung Disease 5/13/2013  More...
Optimer Pharmaceuticals, Inc. (OPTR)'s DIFICID® Tablets Approved in Australia 4/26/2013  More...
European Commission (EC) Gives Green Light to New 6-in-1 Childhood Vaccine From Sanofi Pasteur (SASY.PA) 4/23/2013  More...
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive 4/23/2013  More...
BioAlliance Pharma's Sitavig® Receives Market Authorization in the U.S. for the Treatment of Herpes Labialis 4/16/2013  More...
Sun Pharmaceutical Industries Ltd Gets FDA Nod for Generic Version of Januvia 4/16/2013  More...
Warner Chilcott, PLC (WCRX) Receives FDA Approval of DORYX Delayed-Release 200 Mg Tablets 4/12/2013  More...
FDA Approves Duchesnay's Diclegis for Morning Sickness 4/9/2013  More...
Genzyme Corporation (GENZ)'s AUBAGIO® Approved in Argentina for MS 4/8/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval for Oral Contraceptive 4/2/2013  More...
Astellas Pharma Inc. (YPH.BE)'s Acofide Approved in Japan 3/29/2013  More...
Bayer AG (BAY.F)'s Colorectal Cancer Drug Stivarga Bags Approval in Japan 3/26/2013  More...
Novartis AG (NVS)' TOBI Podhaler Gets FDA Approval 3/25/2013  More...
Genmab A/S (GEN.CO) and GlaxoSmithKline (GSK)'s Arzerra Receives Approval in Japan 3/25/2013  More...
Pfizer Inc. (PFE)'s XELJANZ Receives Approval in Japan 3/25/2013  More...
Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX) Type I Gaucher Disease Drug Uplyso Gets Brazilian Approval 3/19/2013  More...
Novartis AG (NVS) Says Alcon, Inc. (ACL)'s Eye Drug Jetrea Gets EU Approval 3/18/2013  More...
EU Approves Roche (RHHBY)'s Perjeta to Treat Metastatic Breast Cancer 3/6/2013  More...
Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO) Wins Approval for Monthly Abilify Shot 3/1/2013  More...
Novartis AG (NVS)'s Ilaris Cleared for Gouty Arthritis in EU 3/1/2013  More...
Novozymes Biopharma's rAlbumin Approved in Japan as MAQUET Expands Into New Market 2/28/2013  More...
Lundbeck Inc. (LUN.CO) Given EU Nod for Alcohol Dependence Drug 2/28/2013  More...
FDA Approves Shionogi, Inc.'s Drug for Painful Intercourse in Women 2/27/2013  More...
Pfizer Inc. (PFE) Gains China Approval of Drug for Kinase-Specific Lung Cancer 2/26/2013  More...
FDA Approves Genentech (RHHBY)'s Drug for Late-Stage Metastatic Breast Cancer 2/26/2013  More...
Lupin Ltd. (LUPN.BO) Receives FDA Nod for Suprax Oral Suspension 2/22/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval of Generic Adderall XR® 2/15/2013  More...
Torrent Pharmaceuticals Ltd. Gains on FDA Nod for Generics of Actos 2/15/2013  More...
Aurobindo Pharma Gets FDA Nod for Anti-Diabetes Drug 2/15/2013  More...
Celgene Corporation (CELG) Gains SFDA Approval for Multiple Myeloma Treatment 2/13/2013  More...
Sun Pharmaceutical Industries Ltd Receives U.S. Nod for Cancer Drug "Doxil" 2/7/2013  More...
FDA OKs Warner Chilcott, PLC (WCRX)'s Ulcerative Colitis Product 2/6/2013  More...
Sanofi (France) (SAN.PA) Says Zaltrap Approved in Europe for Bowel Cancer 2/5/2013  More...
Sanofi (France) (SAN.PA)'s Diabetes Drug Lyxumia Approved in Europe 2/4/2013  More...
FDA Approves 3 New Diabetes Drugs From Takeda Pharmaceutical Co. Ltd. (TKPYY) 1/29/2013  More...
Meda AB (MEDA-A.ST)'s Dymista Approved in Europe 1/24/2013  More...
FDA Approves Novartis AG (NVS)'s Exjade in Patients With Genetic Blood Disorder 1/24/2013  More...
Lupin Ltd. (LUPN.BO) Gets U.S. Nod for 7th Oral Contraceptive 1/23/2013  More...
Novartis AG (NVS) Wins EU Backing for First Meningitis B Vaccine 1/22/2013  More...
Novo Nordisk A/S (NVO) Gets Green Light for Tresiba in EU 1/22/2013  More...
ThromboGenics NV (TBGNF), Novartis AG (NVS) Win EU OK for Jetrea Eye Drug 1/21/2013  More...
EU Approves Johnson & Johnson (JNJ)'s Single Pill Prezista for HIV 1/16/2013  More...
Janssen-Cilag AG Release: ZYTIGA® Approved in the EU for Use in the Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy 1/11/2013  More...
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis Approved in Japan 12/27/2012  More...
UCB, Inc. (UCBJF.PK) Gets Japan Clearance for Two New Drugs 12/27/2012  More...
Novo Nordisk A/S (NVO) Gains as Japan Approves Ryzodeg 12/27/2012  More...
FDA Approves Roche (RHHBY)'s Tamiflu for Infants 12/27/2012  More...
Biotest AG Receives FDA Approval for BIVIGAM to Treat Primary Humoral Immunodeficiency 12/26/2012  More...
BioAlliance Pharma Announces the Registration of Sitavig® in European Countries 12/21/2012  More...
FDA Approves GlaxoSmithKline (GSK) Drug for Treatment of Anthrax 12/18/2012  More...
FDA Approves GlaxoSmithKline (GSK)'s Four-Strain Seasonal Influenza Vaccine for Use in the U.S. 12/17/2012  More...
Roche (RHHBY) Wins EU Backing for Perjeta Breast Cancer Drug 12/14/2012  More...
European Commission (EC) Clears Wider Use for Genzyme Corporation (GENZ) Cancer Treatment 12/7/2012  More...
Emerging World Pharma Inc. Strategic Partner African Global Pharma (AGP) GH Receives Ghana Food and Drug Board Packaging and Insert Approvals for Paracetamol Tablets 12/6/2012  More...
Trimedica Limited: European Commission (EC) Approves New Xaluprine Formulation 12/5/2012  More...
AstraZeneca PLC (AZN) Heart Drug Wins Approval in China 11/30/2012  More...
Emerging World Pharma Inc. Strategic Partner African Global Pharma (AGP) Approval From Food & Drugs Board Ghana for Anti-Malarial Pharmaceutical Gloderp® in Final Stages 11/28/2012  More...
Almirall, Ironwood Pharmaceuticals Drug for IBS Gets Regulatory Approval in Europe 11/28/2012  More...
Bayer AG (BAY.F)'s Eylea Gets Green Light in Europe for Wet AMD 11/27/2012  More...
All Wales Strategic Medical Group Approves Zebinix Anti-Epileptic Treatment 11/26/2012  More...
FDA Approves Novel Novartis AG (NVS) Seasonal Flu Vaccine 11/26/2012  More...
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ)'s Once-Daily, Oral Aubagio Approved in Australia to Treat MS 11/26/2012  More...
Bristol-Myers Squibb Company (BMY)-Pfizer Inc. (PFE) Anticlot Drug Gets Key EU Approval 11/23/2012  More...
GlaxoSmithKline (GSK) Receives FDA OK for PROMACTA 11/23/2012  More...
EU OKs Bristol-Myers Squibb Company (BMY)-AstraZeneca PLC (AZN) Diabetes Drug After U.S. Rejection 11/16/2012  More...
Syngenta Corporation Secures EU Approval For Next Generation Fungicide 11/13/2012  More...
Sihuan Pharmaceutical Holdings Group Ltd. Announces SFDA Approval for Ulcer Drug 11/2/2012  More...
European Commission (EC) OKs uniQure's First High-Price Gene Therapy for Rare Disease 11/2/2012  More...
FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Leukemia Drug 10/30/2012  More...
Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY) Release: EU Approval Granted for Trajenta® (linagliptin) Tablets as Add-on Therapy to Insulin in Adults With Type 2 Diabetes 10/26/2012  More...
Novartis AG (NVS) Drug Certican® Approved by European Health Authorities to Prevent Organ Rejection in Adult Liver Transplant Patients 10/25/2012  More...
Scil Proteins GmbH Obtains European Medicines Agency Approval for Commercial Production of Reteplase 10/22/2012  More...
ViroPharma Incorporated (VPHM) Release: Health Canada Approves New Drug Submission for Cinryze™ (C1 Inhibitor [Human]) 10/22/2012  More...
FDA: ThromboGenics NV (TBGNF) Main Drug Cleared for U.S. Launch 10/18/2012  More...
Bayer AG (BAY.F)'s Contraceptive Flexyess Gets EU Approval 10/10/2012  More...
InterMune, Inc. (ITMN) Release: Health Canada Approves Esbriet® as First Treatment for Fatal Lung Disease 10/3/2012  More...
Johnson & Johnson (JNJ)'s Janssen-Cilag International NV (JNJ) Gets EC Approval for DACOGEN in AML 10/1/2012  More...
Novartis AG (NVS)'s Smokers' Cough Treatment Gets European Nod 10/1/2012  More...
Novo Nordisk A/S (NVO) Says Diabetes Drug Approved in Japan 9/28/2012  More...
Janssen-Cilag International NV (JNJ)'s Subcutaneous VELCADE® Approved in the EU for the Treatment of Multiple Myeloma 9/28/2012  More...
Astex Pharmaceuticals (ASTX) Says EU OKs Marketing for its Leukemia Drug 9/28/2012  More...
Protalix Biotherapeutics, Inc. (PLX) Receives Marketing Authorization for Elelyso™ for the Treatment of Gaucher Disease From the Israeli Ministry of Health 9/27/2012  More...





 

//-->